Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Multicenter Cohort Study) III
Inflammatory Response and Anti-inflammatory Action for Aortopathy & Arteriopathy (5A-Plan): A Multicenter Cohort Study
1 other identifier
observational
2,000
1 country
1
Brief Summary
Anatomopathological classifications have been well identified in aortic dissection with important therapeutic implications. The authors evaluated the inflammatory response in patients with aortic dissection (AD) and assessed the presence of distinct inflammatory subphenotypes within this disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2021
CompletedFirst Submitted
Initial submission to the registry
June 3, 2021
CompletedFirst Posted
Study publicly available on registry
June 8, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2021
CompletedNovember 20, 2024
November 1, 2024
8 months
June 3, 2021
November 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
30-day mortality
any cause death within 30 days of surgery
30 days after surgery
Secondary Outcomes (1)
ICU mortality
7 days after surgery
Study Arms (1)
inflammatory subphenotype
Interventions
laboratory data (leukocyte, neutrophils, monocyte, lymphocytes, platelet, fibrinogen, D-dimer, neutrophils-lymphocyte ratio, platelet-lymphocyte ratio, lymphocyte-monocyte ratio)
Eligibility Criteria
Patients underwent venipuncture during primary evaluation in the Emergency Department. Venous blood samples were immediately sent to the laboratory for analysis.
You may qualify if:
- acute type Aortic dissection;
You may not qualify if:
- Iatrogenic aortic dissection OR traumatic aortic dissection
- Patients with hematological diseases, infectious diseases, malignant tumors, immune system diseases, or severe liver diseases.
- Preoperative use of mechanical ventilation, blood transfusion, renal replacement therapy, extracorporeal membrane oxygenation, or intra-aortic balloon pump during the current admission.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nanjing Medical Universitylead
- The First Affiliated Hospital with Nanjing Medical Universitycollaborator
- Beijing Anzhen Hospitalcollaborator
- The Affiliated Hospital of Qingdao Universitycollaborator
- First Affiliated Hospital of Shantou University Medical Collegecollaborator
- The First Affiliated Hospital of Guangzhou Medical Universitycollaborator
- TEDA International Cardiovascular Hospitalcollaborator
- Xiamen Cardiovascular Hospitalcollaborator
- Shanghai East Hospital Tongji Universitycollaborator
- Tianjin Chest Hospital, Tianjin Medical Universitycollaborator
- Nanjing First Hospital, Nanjing Medical Universitycollaborator
- Xiangya Hospital of Central South Universitycollaborator
- The First Affiliated Hospital of Bengbu Medical Universitycollaborator
Study Sites (1)
The first affiliated hospital of nanjing medical university
Nanjing, Jiangsu, 210029, China
Related Publications (5)
Liu H, Zhang YY, Ding XH, Qian SC, Sun MY, Hamzah AW, Gao YN, Shao YF, Li HY, Wang K, Ni BQ, Zhang HJ; Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (5A) Investigators. Proximal vs Extensive Repair in Acute Type A Aortic Dissection Surgery. Ann Thorac Surg. 2023 Aug;116(2):270-278. doi: 10.1016/j.athoracsur.2023.04.019. Epub 2023 Apr 25.
PMID: 37105511DERIVEDLiu H, Qian SC, Shao YF, Li HY, Zhang HJ; 5A Investigators. Prognostic Impact of Systemic Coagulation-Inflammation Index in Acute Type A Aortic Dissection Surgery. JACC Asia. 2022 Oct 4;2(6):763-776. doi: 10.1016/j.jacasi.2022.06.007. eCollection 2022 Nov.
PMID: 36444319DERIVEDLiu H, Qian SC, Han L, Dong ZQ, Shao YF, Li HY, Zhang W, Zhang HJ. Laboratory signatures differentiate the tolerance to hypothermic circulatory arrest in acute type A aortic dissection surgery. Interact Cardiovasc Thorac Surg. 2022 Nov 8;35(6):ivac267. doi: 10.1093/icvts/ivac267.
PMID: 36271847DERIVEDLiu H, Qian SC, Zhang YY, Wu Y, Hong L, Yang JN, Zhong JS, Wang YQ, Wu DK, Fan GL, Chen JQ, Zhang SQ, Peng XX, Shao YF, Li HY, Zhang HJ. A Novel Inflammation-Based Risk Score Predicts Mortality in Acute Type A Aortic Dissection Surgery: The Additive Anti-inflammatory Action for Aortopathy and Arteriopathy Score. Mayo Clin Proc Innov Qual Outcomes. 2022 Sep 25;6(6):497-510. doi: 10.1016/j.mayocpiqo.2022.08.005. eCollection 2022 Dec.
PMID: 36185465DERIVEDLiu H, Qian SC, Shao YF, Li HY; Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (5A) Investigators Group. Anti-Inflammatory Effect of Ulinastatin on the Association Between Inflammatory Phenotypes in Acute Type A Aortic Dissection. J Inflamm Res. 2022 Jun 27;15:3709-3718. doi: 10.2147/JIR.S369703. eCollection 2022.
PMID: 35783246DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Investigator of Nanjing Medical University
Study Record Dates
First Submitted
June 3, 2021
First Posted
June 8, 2021
Study Start
January 1, 2021
Primary Completion
August 30, 2021
Study Completion
August 30, 2021
Last Updated
November 20, 2024
Record last verified: 2024-11